Company: PTPI
Filing Date: 2025-02-10
Form Type: S-1/A
Source: 0001410578-25-000108
Chunk: 284

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-10
Form: S-1/A
Chunk 284
---
, 2025, the Company amended the Plan (the “Plan Amendment”) to remove certain individual limitations on the number of stock options, stock appreciation rights, shares of restricted stock and restricted stock units that could be awarded to an employee participant in any fiscal year pursuant to Section 4(d) of the Plan.

<div align='center'>F-55</div>

#### Up to 74,349,442 Units, Each Unit Consisting of One Share of Common Stock or OnePre-Funded Warrants to Purchase One Share of Common Stock, One Series AWarrant to Purchase One Share of Common Stock and One Series BWarrant to Purchase One Share of Common StockUp to 223,048,326 Shares of Common Stock Underlying the Pre-Funded Warrants, Series AWarrants and Series B WarrantsPROSPECTUSDawson James Securities, Inc., 2025​​
#### ​

PART II INFORMATION NOT REQUIRED IN PROSPECTUS

| Item 13. | Other Expenses of Issuance and Distribution |

The following table sets forth the fees and expenses, other than placement agent fees and expenses, payable in connection with the registration of the securities hereunder. All amounts are estimates except the SEC registration fee and the FINRA filing fee.

| Item                             | ​ | Amount     
 to be paid |         | ​ |
|:---------------------------------|:--|:-----------|--------:|:--|
| SEC registration fee             | ​ | $          |   9,186 | ​ |
| FINRA filing fee                 | ​ | $          |   7,250 | ​ |
| Printing expenses                | ​ | $          |  10,000 | ​ |
| Legal fees and expenses          | ​ | $          | 100,000 | ​ |
| Accounting fees and expenses     | ​ | $          |  60,000 | ​ |
| Transfer Agent fees and expenses | ​ | $          |  10,000 | ​ |
| Total                            | ​ | $          | 196,436 | ​ |

| Item 14. | Indemnification of Directors and Officers |

Section 102 of the Delaware General Corporation Law allows a corporation to eliminate the personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved